GovChime
Notice ID: 74c7c15d823d41ef80bbab4f1bf92ac5Award NoticeAwarded

National Drug Data File Renewal

Awarded on May 19, 2023. Full description on SAM.gov.

Awarded tounder 75FCMC23P0013 (source: SAM.gov award notice)• $123.2K

Overview

Posted
May 22, 2023
Notice type
Award Notice
NAICS
513199: All Other Publishers
Agency
Department of Health and Human ServicesCENTERS FOR MEDICARE AND MEDICAID SERVICES

Notice details

Office
OFC OF ACQUISITION AND GRANTS MGMT
Place of performance
Windsor Mill, 21244
Last updated
Oct 8, 2026
Award date
May 19, 2023
Award amount (SAM.gov award notice)
$123.2K

Identifiers

Solicitation number
CMMI-393-2023-0068-RAW
Notice ID
74c7c15d823d41ef80bbab4f1bf92ac5
Award number (PIID)
75FCMC23P0013

Description

This purchase order was made to First DataBank as a sole source because the data collection service is proprietary to First DataBank.

Full description on SAM.gov

Award Overview

Award Number

75FCMC23P0013

Award Amount (SAM.gov award notice)

$123.2K

Award Date

May 19, 2023

Awardee

Awardee UEI

VMQNWNFBZ7R9

Awardee CAGE Code

1V6D0

Original Solicitation

Notice ID: 74c7c15d823d41ef80bbab4f1bf92ac5

Posted Date: May 22, 2023

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 75FCMC25PJ032
    FIRST DATABANK INC
    Department of Health and Human ServicesNAICS 513199
    $1.2MSigned Sep 23, 2026
  • 75FCMC25PJ032
    FIRST DATABANK INC
    Department of Health and Human ServicesNAICS 513199
    $600.0KSigned May 27, 2026
  • 75FCMC25PJ032
    FIRST DATABANK INC
    Department of Health and Human ServicesNAICS 513199
    $600.0KSigned Mar 25, 2026
  • 75FCMC25PJ032
    FIRST DATABANK INC
    Department of Health and Human ServicesNAICS 513199
    $600.0KSigned Mar 20, 2026
  • 75FCMC24P0019
    FIRST DATABANK INC
    Department of Health and Human ServicesNAICS 513199
    $128.1KSigned Mar 4, 2026

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:CMMI-393-2023-0068-RAW
  1. Combined Synopsis
  2. Awarded

This opportunity has been awarded.

  1. 2×
    Combined SynopsisApr 27, 2023

    National Drug Data File Renewal

    Notice a9a2a0e84c4f41a0831823dfb13ecd26 on SAM.gov

  2. AwardedCurrentMay 22, 2023

    National Drug Data File Renewal

    Notice 74c7c15d823d41ef80bbab4f1bf92ac5 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
This is a Sources Sought set aside for Indian Economic Enterprise (IEE) and Indian Small Business Economic (ISBEE). This is NOT a solicitation for proposals, proposal abstracts, or quotations. The objective of this Sources Sought is to identify potential IEE and ISBEE vendor that can provide materials marketing and e-ordering software system services for the Indian Health Service (IHS). ELIGIBLE VENDORS: Businesses MUST be Indian Economic Enterprises (IEEs) (at least 51% Indian owned and controlled). All respondents shall be registered in the System for Award Management (SAM) located at https://www.sam.gov. SMALL BUSINESS STATUS: Provide business size and socioeconomic status (e.g., ISBEE, IEE), along with your UEI, organization name, address, and point of contact. The anticipated NAICS code for this requirement is 513210 - Software Publishers. ADDITIONAL INFORMATION: Provide any additional information that may assist the Government in refining its acquisition strategy or determining whether a competitive set-aside or other RFO-aligned commercial approach is appropriate. Information Submission Instructions: Questions regarding the contents of this Sources Sought shall be submitted via email to: miguel.diaz@hhs.gov no later than 12:00PM, EST on NOVEMEBER 06, 2026. The subject line for the email heading shall be “SSN27-IHS-1532119: Proofpoint Cloud Email Security Services.” Phone calls will not be accepted. The Government reserves the right to respond to some, all, or none of the questions that will be submitted. Capability Statement Submission Instructions: Interested companies should review the attachments and then submit a response that provides feedback, if any, on the attached and that addresses all of the information listed. Capability statements and responses shall be submitted via email to miguel.diaz@hhs.gov no later than 12:00 PM EST on NOVEMBER 06, 2026. The subject line for the email heading shall be “SSN27-IHS-1532119: Proofpoint Cloud Email Security Services.” Please provide enough detail and depth to enable Government review and assessment. Please add a cover letter to your response with the following information: Company Name Company Unique Entity ID number Company points of contact, mailing address, telephone and website address Any Governmentwide Acquisition Contract (GWAC), General Services Administration (GSA) Schedule vehicle, or other available procurement vehicles your company maintains that could meet this requirement Business Size relative to NAICS code 513210 - Software Publishers Type of Company (e.g., large business, small business, 8(a), woman owned, veteran owned, etc.) as registered in the System for Award Management (SAM) Identify any/all teaming arrangements Indian Economic Enterprise (IEE) Representation Form Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or pay for the information provided in response. The Government reserves the right to use information provided by the respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Any solicitation resulting from the analysis of information obtained will be announced to the public in SAM in accordance with FAR Part 5. However, responses to this notice will not be considered adequate to responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). The due date for receipt of statements is NOVEMBER 06, 2026, 12:00 PM, EST. All responses must be received by the specified due date and time in order to be considered. This notice is for information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of HHS. HHS/OMAS does not intend to award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted. As a result of this notice, HHS/OMAS may issue a Request for Quote (RFQ). THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. However, should such a requirement materialize, no basis for claims against HHS shall arise as a result of a response to this notice or HHS’s use of such information as either part of our evaluation process or in developing specifications for any subsequent requirement. Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in SAM.gov. However, responses to this notice will not be considered adequate responses to a solicitation.
-Market Research11/06/2026
Acquisition Description: This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with ArgonSoft. The National Institute of Health (NIH) requires software maintenance and support for the NIH Laboratory Information Management system (LIMS) called ASIS.TO which is designed by Argonsoft. The LIMS was previously installed by ArgonSoft in the NIH CC/ET department under agreement # 75N90023P00826. The required software and support includes: 1 year gold system support, installation of mandatory updates and minor upgrade package, and IQ/OQ of running installation and operation qualification tests. Justification: Argonsoft is the creator and license holder for their software, and they directly provide support and renewal to their software. Thus, they are the sole source vendor that can provide the software maintenance of this customized proprietary software. Place of Performance or Delivery: The estimated Period of Performance is: January 1, 2026 – December 31, 2026 Place of Performance: NIH Clinical Center in Bethesda, MD The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-26-000808) by 9:00 AM eastern standard time on 01/15/2026 to: lu-chang.lu@nih.gov All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
-Pre-Solicitation11/05/2026
Pursuant to FAR Subpart 13.106-1(b), Veterans Health Administration (VHA), Network Contracting Office 5 intends to solicit from a single source for the purchase of DATA COLLECTION AND SURVEY SOFTWARE services from QUALTIRCS (SAM UEI: PR45WM7EWA57). Under the contemplated contract, the vendor will provide data collection and survey software, compatible with current licenses and interconnected workflows and system integrations via proprietary API and data schema. This notice of intent to conduct a sole source acquisition is not a request for competitive proposals. However, any responsible source who believes it is capable of performing the requirement may submit a capability statement, proposal, or quotation, which shall be considered by the agency, only if received by the closing date and time of this notice. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.
-Special Notice10/15/2026
THIS IS A REQUEST FOR INFORMATION (RFI) ONLY In accordance with RFO 15.101(c), this RFI is issued solely for information and planning purposes. It does not constitute a solicitation for proposals, quotations, or abstracts, nor does it obligate the Government to award a contract or pay for any information provided. Responses will not be returned. No reimbursement will be made for costs associated with responding to this notice. 1. Background Research supported and conducted by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (HHS), strives to understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases that threaten millions of human lives. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all infectious agents, an essential component of U.S. efforts to ensure the health and safety of the American people. Through multiple grant- and contract-funded research programs, NIAID supports a broad range of clinical research, including single-site and multi-center trials spanning Phase 0-4 therapeutics and vaccines, new vaccine formulations, schedules, and modes of delivery; surveillance or natural history / cohort studies for pathogens of interest; evaluation of novel diagnostics; and clinical trials designed to find additional uses for already approved therapies for selected infectious diseases. The portfolio includes primarily domestic clinical sites, with the ability to support international studies. As part of clinical research portfolio, NIAID has regulatory obligations for clinical trials that include standardized deliverables, reporting, safety oversight, and monitoring. NIAID therefore requires resources to support its clinical research activities in compliance with regulatory requirements. One of those resources is a Statistical and Data Coordinating Center (SDCC) which provides centralized data management, statistical, and specimen tracking services essential to this clinical research portfolio. NIAID is exploring the re-competition of its Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases (CRID) contract. 2. Purpose The Government is issuing this RFI to: Facilitate early engagement with industry prior to release of a formal Request for Proposals (RFP), in accordance with RFO 15.101(c). Assess current market capabilities and vendor offerings relevant to SDCC services. Gather input on industry best practices to inform development of a future Statement of Work (SOW). Support fair and open competition in accordance with FAR 5.401. 3. Summary of Anticipated Scope and Targeted Feedback The anticipated SDCC contract encompasses the following broad functional areas. Respondents are encouraged to provide specific feedback on each area, including comments on feasibility, gaps, ambiguities, industry best practices, and any suggested refinements. 3.1 Overall Questions Targeted feedback requested: To what extent can or should Artificial Intelligence (AI) tools or platforms be incorporated into the SOW while maintaining confidentially of participant data? 3.2 Data Collection and Management The contractor will operate and maintain a state-of-the-art, 21 CFR Part 11-compliant clinical data system supporting data collection, automated data transfer, validation, storage, and submission to the FDA, from a large portfolio of domestic clinical sites, with the ability to support international studies. Targeted feedback requested: What commercial or proprietary platforms are best suited to support a portfolio of this scale and diversity while also meeting the standards of government-funded computer systems and Food and Drug Administration (FDA) regulatory submissions? What are their strengths and limitations in: an international setting; multi-site protocols; multi-protocol environments; and data collection methods from multiple sources, including electronic health records (EHR), electronic source, and paper source? How should the Statement of Work (SOW) address data system transition and continuity of operations at contract start-up to minimize disruption to ongoing studies? 3.3 Data Quality Assurance and Control The contractor shall provide and maintain a quality control system for monitoring the accuracy, completeness, and timeliness of the data, by study sites at each stage of a study, beginning with study initiation/participant enrollment and proceeding to the generation of final data sets. The system shall provide for verification of 100 percent of study data for audit readiness. Targeted feedback requested: What contractor involvement with development of data standards (i.e., via CDISC working groups and committees) should the SOW require to ensure innovation and continuous improvement in how data are collected? As CDISC and other standards continue to evolve, what mechanisms should the SOW require to ensure ongoing compliance without cost or schedule impact to the Government? 3.4 Protocol and Other Study-Related Materials The contractor shall provide services in the preparation, writing, review, revision, and distribution of protocol-related documents and materials (i.e., Manual of Procedures (MOP)) in collaboration with the study team and in support of implementation of the clinical protocol. Targeted feedback requested: What are industry standard timelines for development of clinical protocols and other study related materials, and what should the SOW require for their delivery schedule? What are industry standard timelines for the development of study data system(s), what best practices are recommended to facilitate rapid development of the data system, and what should the SOW require for the delivery schedule? 3.5 Communication, Collaboration, and Reporting The Contractor shall coordinate and collaborate with NIAID and other NIAID Clinical Research Infrastructure contractors and grant recipients to facilitate study implementation and assess study progress. The Contractor shall operate and maintain a web-based resource to share clinical research information and study materials with the NIAID, the study team, and participating study sites. Targeted feedback requested: What should the SOW require to ensure productive collaborations with multiple other contractors and grant recipients? What are industry standards for resources and platforms that can be used to share clinical research information at fixed costs to the Government? 3.6 Statistical Design and Analysis The Contractor shall provide expertise, advice, and assistance in the development of statistical designs of clinical concepts, statistical analysis plans, and in preparation of interim and final analyses for clinical research activities. Targeted feedback requested: What emerging statistical methodologies (e.g., adaptive trial designs, Bayesian approaches) should the SOW explicitly accommodate, and how should the Government structure tasking to access these capabilities efficiently? What should the SOW require for approaches or platforms for statistical analysis that encompass: standard clinical trial analysis, broad range of –Omics datasets, and generation of publication-ready tables and figures. 3.7 Clinical Site Training and Technical Assistance The Contractor shall train clinical site personnel on data systems and procedures, maintain a 24/7 help desk accessible from domestic and international locations, and assess site capabilities for studies not using SDCC systems. Targeted feedback requested: What are the most significant challenges in supporting clinical sites with respect to data system access, connectivity, and training, and how should the SOW account for them? 3.8 Electronic Specimen Tracking The Contractor shall provide and maintain an electronic specimen tracking system, for use by the SDCC, study sites, laboratories, and NIAID, to track study specimens in real time. Targeted feedback requested: Are there commercially available specimen tracking platforms that integrate natively with clinical data management systems, and should the SOW require such integration or permit modular solutions? 3.9 Data Storage The contractor shall maintain a secure and validated data storage system for clinical research and clinical trial data and analyses from current and future trials. Targeted feedback requested: What should the SOW include as requirements for data storage that allow for occasional data access for analysis while limiting cost to the Government? What should the SOW require for the maintenance of data from completed studies, such that results and performance metrics can be readily accessed from across all studies? 3.10 Data Sharing The contractor shall distribute, transfer, and/or share data and metadata to NIH and NIAID-designated repositories following completion of the clinical trial while ensuring data are appropriately and commensurately de-identified. Targeted feedback requested: What should the SOW require for methods and procedures to reliably de-identify clinical trial data? 3.11 Project Management The contractor shall provide for the overall management, integration and coordination of all contract activities, including the management and coordination of activities carried out under subcontracts if applicable Targeted feedback requested: What are critical elements of program and project management necessary to operate a resource to provide centralized data management and statistical services essential to support a wide variety of clinical research activities across multiple infectious disease programs involving domestic and international sites? 4. Requested Vendor Information In addition to SOW feedback above, respondents are asked to provide: Organizational Overview: Company name, address, UEI number, applicable NAICS code(s), and business size designation. Relevant Experience: Summary of prior or current experience managing SDCC or comparable data coordinating center functions, including scale (number of studies/sites) and therapeutic areas supported. Technical Capabilities: Description of systems, infrastructure, and personnel available to support the functional areas described above. International Experience: Demonstrated capability to support clinical trials at sites outside the United States. Teaming and Subcontracting: Whether your organization anticipates teaming agreements, or subcontracting, and in what functional areas. 5. Submission Instructions Responses should be limited to ten (10) pages or fewer, excluding cover page and organizational information. Submissions must be in PDF format and sent electronically to: Point of Contact: Miranda Adams, Contracting Officer Email: miranda.adams@nih.gov Responses are due no later than July 8, 2026, at 5:00 p.m. EDT. Telephone responses will not be accepted. The Government reserves the right to use any non-proprietary information received for acquisition planning purposes. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s). All submissions become Government property and will not be returned. Disclaimer This RFI is issued solely for information and planning purposes to facilitate the acquisition planning process. It does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future, nor does it restrict the Government as to the ultimate acquisition approach. This notice does NOT obligate the Government to award a contract or otherwise pay for the information provided in response. Further, NIAID is not seeking proposals through this RFI and will not accept unsolicited proposals. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of a solicitation. Any contract that might be awarded based on information received or derived from this RFI will be the outcome of a competitive process. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback with respect to any information submitted. Potential respondents should continue to monitor SAM.gov for any follow-on solicitation or additional information related to this requirement.
-Market Research07/08/2026
This Presolicitation notice is NOT a Request for Quotation (RFQ)/Solicitation, however all responsible sources may submit a capability statement, quotation, bid, or proposal, as appropriate, which will be considered by the agency. The Government intends to award a purchase order to Information Management Services on a sole source basis under the authority of RFO FAR 12.102(a) - Restricting competition. Responses shall be submitted electronically to Jacob Balenson via email to jacob.balenson@nih.gov, and Sandra Daniels sandra.daniels@nih.gov no later than November 25, 2026 at 10:00 AM (Eastern Time). Emails must reference Presolicitation Number 75N98027Q00046 in the subject line. See attached Presolicitation Notice and Statement of Work (SOW) for more information.
-Pre-Solicitation11/25/2026

Additional Details

Solicitation Number

CMMI-393-2023-0068-RAW

Archive Date

Jun 3, 2023

Office Address

BALTIMORE, MD, 21244